Key result
Carbon-ion radiotherapy and chemotherapy after incomplete resection achieves ~4.5-year survival in cardiac spindle cell sarcoma.
Why the study?
Primary cardiac spindle cell sarcoma is a rare malignant neoplasm with poor prognosis and no established evidence-based treatment guidelines.
Case Report (n=1)
No
Incomplete surgical resection combined with postoperative carbon-ion radiotherapy and chemotherapy yielded a relatively long survival of over 4 years in a rare case of primary cardiac spindle cell sarcoma.
Suggests multimodal therapy may extend survival in rare cardiac sarcomas; single case leaves generalizability open.
INTRODUCTION: Primary cardiac sarcoma is a rare malignant cardiac neoplasm with a poor prognosis. No evidence-based guidelines exist regarding surgical treatment management, although some case reports have been published. We report the outcome of a patient with spindle cell sarcoma of the heart treated postoperatively with carbon-ion radiotherapy and chemotherapy. PRESENTATION OF CASE: A 16-year-old female patient was noted to have abnormal electrocardiogram results for 2 consecutive years at a high school medical check. She was referred to our hospital and a cardiac tumor in the left atrium was suspected. The preoperative diagnosis was myxoma, but abnormalities were also observed macroscopically during surgery, and a diagnosis of spindle cell sarcoma was made by rapid intraoperative pathological analysis. We resected the tumor as much as possible with surgery, but the tumor in the left lower pulmonary vein could not be respected. We performed carbon-ion radiotherapy postoperatively. She experienced recurrence 1 year later and tumor growth 2 years later. We considered additional surgical treatment, but eventually selected chemotherapy. She died 4 years and 7 months after initial surgery. CONCLUSION: Spindle cell sarcoma is a rare disease with a poor prognosis. Although no optimal treatment method has been established, in the present case, incomplete surgical resection and postoperative carbon-ion radiotherapy were performed, yielding a relatively long survival period.
No takes yet. Share an insight, caveat, or question.
Shibasaki et al. (2020) conducted a case report in Primary spindle cell sarcoma of the heart (n=1). Incomplete surgical resection, postoperative carbon-ion radiotherapy, and chemotherapy was evaluated on Survival. Incomplete surgical resection followed by postoperative carbon-ion radiotherapy and chemotherapy for primary spindle cell sarcoma of the heart yielded a survival period of 4 years and 7 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: